|
Volumn 199, Issue 4, 2004, Pages 654-655
|
Disseminated plasmablastic lymphoma
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
PREDNISONE;
VINCRISTINE SULFATE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTINEOPLASTIC AGENT;
CHOP PROTOCOL, MODIFIED;
DRUG DERIVATIVE;
VINCRISTINE;
ABDOMINAL DISTENTION;
ANAMNESIS;
ARTICLE;
B CELL LYMPHOMA;
CLINICAL FEATURE;
COLITIS;
DIAGNOSTIC PROCEDURE;
GALLBLADDER DISEASE;
HISTOPATHOLOGY;
HOSPITAL ADMISSION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
MYCOSIS;
NEUTROPENIA;
PHYSICAL EXAMINATION;
PLASMABLASTIC LYMPHOMA;
PRIORITY JOURNAL;
SEPTICEMIA;
SIDE EFFECT;
CASE REPORT;
FATALITY;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LARGE CELL LYMPHOMA;
MALE;
MIDDLE AGED;
ANTI-HIV AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FATAL OUTCOME;
HIV INFECTIONS;
HUMANS;
LYMPHOMA, AIDS-RELATED;
LYMPHOMA, LARGE-CELL, DIFFUSE;
MALE;
MIDDLE AGED;
PREDNISONE;
VINCRISTINE;
|
EID: 6944246370
PISSN: 10727515
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jamcollsurg.2004.03.028 Document Type: Article |
Times cited : (6)
|
References (6)
|